Clinical trial Recruiting at 1 site Interventional Ages 50 to 70

Comparing Otago and Gaze Stabilization Exercises for Balance in Elderly Stroke Patients

Official title: Effects of Otago Exercises and Gaze Stabilization Exercises on Balance, Gait and Quality of Life in Elderly Stroke Patients

Run by Riphah International University · NCT06845709 · Data updated 2026-11-12

This study is testing whether Otago exercises or Gaze Stabilization exercises can help improve balance and quality of life for elderly stroke patients.

Quick facts

Study typeInterventional
Ages50 Years to 70 Years
SexAll
Enrollment46 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Islamabad, Fedral)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedMarch 1, 2025
Study endsApril 15, 2025
Registry record updatedFebruary 25, 2025
Trial IDNCT06845709 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include elderly individuals who have experienced an ischemic or hemorrhagic stroke within the last six months and meet specific balance and cognitive assessment criteria.

Probably not a fit

Patients with severe vision or hearing impairments, other neurological disorders, or those on medications affecting balance may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effects of Otago exercises and Gaze Stabilization exercises on balance, gait, and quality of life in elderly patients who have suffered a stroke. A total of 46 stroke patients will be recruited from Riphah Rehabilitation Center and General Hospital in Lahore, using a randomized clinical trial design. Participants will be divided into two groups, with one group receiving Gaze Stabilization Exercises and the other receiving Otago Exercises, both alongside conventional treatment. Each group will undergo 40-minute sessions, five days a week for eight weeks, with assessments conducted using the Berg Balance Scale, Dynamic Gait Index, and stroke-specific quality of life measures.

Why it matters

Potential benefit: If successful, this study could significantly improve balance and quality of life for elderly stroke patients.

How similar studies have gone: While similar approaches have been explored, this specific comparison of Otago and Gaze Stabilization exercises in elderly stroke patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Had ischemic or haemorrhagic stroke ≤6 months
* Berg Balance Scale (BBS) score between 35 and 45
* Dynamic Gait Index score between 11 and 19
* Mini-mental status exam scores \> 24

Exclusion Criteria:

* Participants with severe vision or hearing impairment
* Neurological disorders including epilepsy, Alzheimer's disease, vertigo, Parkinson disease, and stroke, muscular disorders which limit functional activity (OA, RA, etc)
* Medications that affect balance, severe cardiovascular conditions, recent lower limb injury or surgery
* Peripheral vestibular disorder

Where it's running

  • Riphah International University
    Islamabad, Fedral, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Dr.Zeest Hashmi, MSNMPT — Riphah International University
  • Study coordinator: Zeest Hashmi, MS NMPT
  • Email: zeesthashmi1@gmail.com
  • Phone: 03224655851

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.